TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
BWT Pharma & Biotech AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
735,019
|
484,991
|
332,340 |
| Financial expenses |
195
|
7
|
45 |
| Earnings before taxes |
155,957
|
77,867
|
48,243 |
| EBITDA |
151,919
|
76,231
|
48,586 |
| Total assets |
534,041
|
355,614
|
202,543 |
| Current assets |
532,030
|
354,097
|
201,045 |
| Current liabilities |
353,534
|
258,862
|
139,065 |
| Equity capital |
178,151
|
94,787
|
53,218 |
| - share capital |
500
|
500
|
500 |
| Employees (average) |
50
|
48
|
42 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
33.4%
|
26.7%
|
26.3% |
| Turnover per employee |
14,700
|
10,104
|
7,913 |
| Profit as a percentage of turnover |
21.2%
|
16.1%
|
14.5% |
| Return on assets (ROA) |
29.2%
|
21.9%
|
23.8% |
| Current ratio |
150.5%
|
136.8%
|
144.6% |
| Return on equity (ROE) |
87.5%
|
82.1%
|
90.7% |
| Change turnover |
250,028
|
152,651
|
129,258 |
| Change turnover % |
52%
|
46%
|
64% |
| Chg. No. of employees |
2
|
6
|
5 |
| Chg. No. of employees % |
4%
|
14%
|
14% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.